(2018). Simultaneous treatment of moderate-to-severe horizontal frontalis lines, glabellar lines, and lateral canthal lines with onabotulinumtoxinA, from the subject’s perspective: Patient-reported satisfaction and impact outcomes from a phase 3 double-blind study. Journal of the American Academy of Dermatology, 79(3), AB262. https://doi.org/10.1016/j.jaad.2018.05.1037
Chicago Style (17th ed.) Citation"Simultaneous Treatment of Moderate-to-severe Horizontal Frontalis Lines, Glabellar Lines, and Lateral Canthal Lines with OnabotulinumtoxinA, from the Subject’s Perspective: Patient-reported Satisfaction and Impact Outcomes from a Phase 3 Double-blind Study." Journal of the American Academy of Dermatology 79, no. 3 (2018): AB262. https://doi.org/10.1016/j.jaad.2018.05.1037.
MLA (9th ed.) Citation"Simultaneous Treatment of Moderate-to-severe Horizontal Frontalis Lines, Glabellar Lines, and Lateral Canthal Lines with OnabotulinumtoxinA, from the Subject’s Perspective: Patient-reported Satisfaction and Impact Outcomes from a Phase 3 Double-blind Study." Journal of the American Academy of Dermatology, vol. 79, no. 3, 2018, p. AB262, https://doi.org/10.1016/j.jaad.2018.05.1037.